THREE YEARS OBSERVATION OF TRIOGESIC IN THE TREATMENT OF MIGRAINE.
D000293:Adolescent; D000698:Analgesia; D035843:Biomedical Research; D002648:Child; D004358:Drug Therapy; D004878:Ergotamine; D008298:Maleates; D008881:Migraine Disorders; D059408:Pain Management; D010665:Phenylpropanolamine; D012852:Sinusitis; D013566:Sympathomimetics
D008298:Maleates; D013566:Sympathomimetics; D010665:Phenylpropanolamine; D004878:Ergotamine
ADOLESCENCE; ANALGESIA; CHILD; CLINICAL RESEARCH; DRUG THERAPY; ERGOTAMINE; MALEATES; MIGRAINE; PHENYLPROPANOLAMINE; SINUSITIS; SYMPATHOMIMETICS